Drug Development

Cancer Drugs Reverse Alzheimer’s Pathology in Mice, Advance to Clinical Trials

Researchers are preparing human trials of letrozole and irinotecan after electronic health data linked the combo to lower Alzheimer’s risk, mindful of its side-effect profile